Detection and treatment of early cancer in high-risk populations

Best Practice and Research: Clinical Gastroenterology

Volumn 20, Issue 4, 2006, Pages 745-765

  Yoshida, Shigeaki ^a   Kozu, Takahiro ^b   Gotoda, Takuji ^d   Saito, Daizo ^c  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b NATIONAL CANCER CENTER   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

^d NONE

Author keywords

cancer screening; detailed endoscopy; early gastric cancer; EMR; endoscopic treatment; endoscopic barium surveillance; ESD; gastrin; Helicobacter pylori; high risk population; histological type; pepsinogen; smoking

Indexed keywords

GASTRIN; PEPSINOGEN I; PEPSINOGEN II;

AGING; CANCER CLASSIFICATION; CANCER RISK; CANCER SCREENING; CIGARETTE SMOKING; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; EARLY CANCER; EARLY DIAGNOSIS; ENDOSCOPIC MUCOSAL RESECTION; ENDOSCOPIC SUBMUCOSAL DISSECTION; ENDOSCOPIC SURGERY; GASTRITIS; GASTROSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HIGH RISK POPULATION; HUMAN; JAPAN; PROTEIN BLOOD LEVEL; REVIEW; SEX DIFFERENCE; SKILL; STOMACH CANCER; STOMACH MUCOSA; WESTERN HEMISPHERE;

ENDOSCOPY, GASTROINTESTINAL; GASTRECTOMY; HUMANS; MASS SCREENING; RISK FACTORS; STOMACH NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33748678897     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2006.01.001     Document Type: Review

References (53)

1. Nishino Y., Suzuki Y., Ohmori K., et al. Cancer incidence profiles in the Miyagi Cohort Study. J Epidemiol supplement 1 (2004) S7-S11
2. Ajiki W., Tsukuma H., and Oshima A. Trends in cancer incidence and survival in Osaka. Cancer mortality and morbidity statistics: Japan and the World-2004. In: Tajima K., Kuroishi T., and Oshima A. (Eds). Gann Monograph on Cancer Research Vol. 51 (2004), Japan Sci Soc Press, Tokyo 137-163
3. Lambert R., Guiloux A., Oshima A., et al. Incidence and mortality from stomach cancer in Japan, Slovenia and the USA. Int J Cancer 97 (2002) 811-818
4. Sasazuki S., Sasaki S., and Tsugane S. Japan Public Health Center Study Group: cigarette smoking, alcohol consumption and subsequent gastric cancer risk by subsite and histologic type. Int J Cancer 101 (2002) 560-566
5. Gonzalez C.A., Pera G., Agudo A., et al. Smoking and the risk of gastric cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). Int J Cancer 107 (2003) 629-634
6. Minami Y., and Tateno H. Associations between cigarette smoking and the risk of four leading cancers in Miyagi Prefecture, Japan: a multi-site case-control study. Cancer Sci 94 (2003) 540-547
7. Koizumi Y., Tsubono Y., Nakaya N., et al. Cigarette smoking and the risk of gastric cancer: a pooled analysis of two prospective studies in Japan. Int J Cancer 112 (2004) 1049-1055
8. Hermanek P., and Wittekind C. Histological typing and grading of gastric carcinoma. In: Nishi M., Ichikawa H., Nakajima T., and Tahara E. (Eds). Gastric Cancer (1993), Springer, Tokyo 40-52
9. Aoki K. Epidemiology of stomach cancer. In: Nishi M., Ichikawa H., Nakajima T., and Tahara E. (Eds). Gastric Cancer (1993), Springer, Tokyo 2-15
10. Caruso R.A., Finociaro G., Bersiga A., et al. Clinicopathological features of early gastric cancer in younger versus older patients in a high incidence area of northern Italy. Ital J Gastroenterol Hepatol 29 (1997) 138-142
11. Parsonnet J., Friedman C.D., Vandersteen D.P., et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325 (1991) 1127-1131
12. International Agency for Research on Cancer (IACR) Working Group. IARC Monographs on the Evaluation of Carcinogenic Risk to Humans. Shistosomas, Liver flukes and Helicobacter pylori Vol. 61 (1994), IARC, Lyon (France) p. 218
13. Kato I., Tominaga S., Ito Y., et al. A prospective study of atrophic gastritis and stomach cancer risk. Jpn J Cancer Res 84 (1992) 1137-1142
14. Sugiyama A., Maruta F., Ikeno T., et al. Helicobacter pylori infection enhances N-methyl-N-nitrosourea-induced stomach carcinogenesis in the Mongolian gerbil. Cancer Res 58 (1998) 2067-2069
15. Nozaki K., Shimizu N., Ikehara Y., et al. Effect of early eradication on Helicobacter pylori-related gastric carcinogenesis in Mongolian gerbils. Cancer Sci 94 (2003) 235-239
16. Yamagata H., Kiyohara Y., Aoyagi K., et al. Impact of Helicobacter pylori infection on gastric cancer incidence in a general Japanese population: the Hisayama study. Arch Intern Med 160 (2000) 1962-1968
17. Uemura N., Okamoto S., Yamamoto S., et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345 (2001) 784-789
18. Wong B.C., Lam S.K., Wong W.M., et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 291 (2004) 187-194
19. Saito D, Boku N, Fujioka T et al. Impact of H. pylori eradication on gastric cancer prevention. A randomized multi-center trial. Proc DDW USA 2005 #23, Chicago, USA.
20. Ley C., Monhar A., Guarner J., et al. Helicobacter pylori eradication and gastric preneoplastic conditions: a randomized, double-blind, placebo-controlled trial. Cancer Epidemiol Biomarkers Prev 13 (2004) 4-10
21. Miki K., Ichinose M., Kawamura N., et al. The significance of low serum pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects. Jpn J Cancer Res 80 (1989) 111-114
22. Miki K., Morita M., Sasajima M., et al. Usefulness of gastric cancer screening using the serum pepsinogen test method. Am J Gastroenterol 98 (2003) 735-739
23. Dinis-Ribeiro M., Yamaki G., Miki K., et al. Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening. J Med Screen 11 (2004) 141-147
24. Shipponen P., Ranta P., Helske Y., et al. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study. Scand J Gastroenterol 37 (2002) 785-791
25. Vaananen H., Vauhkonen M., Helske T., et al. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol 15 (2003) 885-891
26. Hartleb M., Wandzel P., Waluga M., et al. Non-endoscopic diagnosis of multifocal atrophic gastritis; efficacy of serum gastrin-17, pepsinogens and Helicobacter pylori antibodies. Acta Gastroenterol Belg 67 (2004) 320-326
27. Remboasz K., Konturek P.C., Karcz D., et al. Biomarkers in various types of atrophic gastritis and their diagnostic usefulness. Dig Dis Sci 50 (2005) 474-482
28. Germana B., Di Mario F., Cavallaro L.G., et al. Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacter pylori antibodies in the management of dyspeptic patients in primary care. Dig Liver Dis 37 (2005) 501-508
29. Henwood M., Clarke P.A., Smith A.M., and Watson S.A. Expression of gastrin in developing gastric adenocarcinoma. Br J Surg 88 (2001) 564-568
30. Synergistic inhibitory effects of gastrin and histamine receptor antagonists on Helicobacter-induced gastric cancer. Gastroenterology 128 (2005) 1965-1983
31. Expression of some tumor associated factors in human carcinogenesis and development of gastric carcinoma. World J Gastroenterol 11 (2005) 3217-3221
32. Yoshida S., Yoshimori M., Hirashima T., et al. Nonulcerative lesion detected by endoscopy as an early expression of gastric malignancy. Jpn J Clin Oncol 11 (1981) 495-506
33. Yoshida S., Yamaguchi H., Tajiri H., et al. Diagnosis of early gastric cancer seen as less malignant endoscopically. Jpn J Clin Oncol 14 (1984) 225-241
34. Yoshida S., Yamaguchi H., Saito D., and Kido M. Endoscopic diagnosis; latest trends. In: Nishi M., Ichikawa H., Nakajima T., and Tahara E. (Eds). Gastric Cancer (1993), Springer, Tokyo 246-262
35. Hosokawa O., Tsuda S., Kidani E., et al. Diagnosis of gastric cancer up to three years after negative upper gastrointestinal endoscopy. Endoscopy 30 (1998) 669-674
36. Hosokawa O., Watanabe K., Hattori M., et al. Endoscopic surveillance for gastric remnant cancer after early cancer surgery. Endoscopy 34 (2002) 469-473
37. Deyhle P., Largiader F., Jenny S., et al. A method for endoscopic electroresection of sessile colonic polyps. Endoscopy 5 (1973) 38-40
38. Tada M., Karita M., and Yanai M. Treatment of early gastric cancer using strip biopsy: a new technique for jumbo biopsy. In: Takemoto T., and Kawai K. (Eds). Recent Topics of Digestive Endoscopy (1987), Japan Excerpta Medica, Tokyo 137-142
39. Inoue H., Endo M., Takeshita K., et al. A new simplified technique of endoscopic esophageal mucosal resection using a cap-fitted panendoscope (EMRC). Surg Endosc 6 5 (1992 Sep-Oct) 264-265
40. Hirao M., Takakuwa R., Kawashima H., et al. ERHSE (endoscopic resection with local injection of hypertonic saline epinephrine solution) for the treatment of early gastric cancer. Stomach and Intestine 23 (1988) 399-409 [in Japanese with English summary]
41. Hosokawa K., and Yoshida S. Recent advances in endoscopic mucosal resection for early gastric cancer. Gan To Kagaku Ryoho 25 (1998) 476-483 [in Japanese with English summary]
42. Ono H. Endoscopic submucosal dissection for early gastric cancer. Chin J Dig Dis 6 3 (2005) 119-121
43. Oyama T., Tomori A., Hotta K., et al. Endoscopic submucosal dissection of early esophageal cancer. Clin Gastroenterol Hepatol 3 7 supplement 1 (2005) S67-S70
44. Gotoda T., Yanagisawa A., Sasako M., et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer 3 (2000) 219-225
45. Minami S., Gotoda T., Ono H., et al. Complete endoscopic closure using endoclips for gastric perforation during endoscopic resection for early gastric cancer can avoid emergent surgery. Gastrointest Endosc 63 (2006) 591-601
46. Yoshida S., and Saito D. Gastric premalignancy and cancer screening in high-risk patients. Am J Gastroenterol 91 (1996) 839-843
47. Ochiai A., and Hirohashi S. p53 Mutation in the non-neoplastic intestinal metaplasia of the human stomach. Int J Cancer 65 (1996) 1-6
48. Yokozaki H., Kuniyasu H., Semba S., et al. Molecular bases of human stomach carcinogenesis. In: Tahara H. (Ed). Molecular Pathology of Castroenterological Cancer (1997), Springer-Verlag, Tokyo 55-70
49. Nakamura E., Sugihara H., Banba M., and Hattori T. Dynamic alteration of the E-cadherin/catenin complex during cell differentiation and invasion of undifferentiated-type gastric carcinomas. J Pathol 205 (2005) 349-358
50. Saito S., Kitayama J., Jin Z.X., et al. Beta-chemokine, macrophage inflammatory protein-1β (MIP-1β), is highly expressed in diffuse type human gastric cancers. J Exp Clin Cancer Res 22 (2003) 453-459
51. Tsugane S., Ssasazuki S., Kobayashi M., and Sasaki S. Salt and salted food intake and subsequent risk of gastric cancer among middle-aged Japanese men and women. Br J Cancer 90 (2004) 128-134
52. Fukuda H., Saito D., Hayashi S., et al. Helicobacter pylori infection, serum pepsinogen level and gastric cancer: a case-control study in Japan. Jpn J Cancer Res 86 (1995) 64-71
53. Kobayashi T., Gotoda T., Tamakawa K., et al. Magnetic anchor for more effective endoscopic mucosal resection. Jpn J Clin Oncol 34 (2004) 118-123